|
184
|
1121
|
7e3lA |
Ultrapotent sars-cov-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants |
|
167
|
1118
|
7edfA |
Cryo-em structure of sars-cov-2 s-uk variant (b.1.1.7), one rbd-up conformation 1 |
|
165
|
1118
|
7edgA |
Cryo-em structure of sars-cov-2 s-uk variant (b.1.1.7), one rbd-up conformation 2 |
|
139
|
596
|
7edjI |
Cryo-em structure of sars-cov-2 s-uk variant (b.1.1.7) in complex with angiotensin-converting enzyme 2 (ace2) ectodomain |
|
31
|
221
|
7e3lD |
Ultrapotent sars-cov-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants |
|
158
|
1118
|
7ediA |
Cryo-em structure of sars-cov-2 s-uk variant (b.1.1.7), two rbd-up conformation |
|
143
|
1118
|
7edjA |
Cryo-em structure of sars-cov-2 s-uk variant (b.1.1.7) in complex with angiotensin-converting enzyme 2 (ace2) ectodomain |
|
49
|
124
|
7cotA |
Structure of post fusion core of sars-cov-2 s2 subunit |
|
24
|
215
|
7e3kE |
Ultrapotent sars-cov-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants |
|
29
|
221
|
7e3kD |
Ultrapotent sars-cov-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants |
|
23
|
201
|
7f62A |
Cryo-em structure of sars-cov-2 spike in complex with a neutralizing antibody chab-25 (focused refinement of s-rbd and chab-25 region) |
|
196
|
1126
|
7n9cA |
Potent neutralizing nanobodies resist convergent circulating variants of sars-cov-2 by targeting novel and conserved epitopes-covs with nb95 |
|
44
|
214
|
7rkvF |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c118 (state 1) |
|
12
|
106
|
7rw2J |
Cryo-em structure of ntd-directed neutralizing antibody 5-7 in complex with prefusion sars-cov-2 spike glycoprotein |
|
193
|
1132
|
7rw2A |
Cryo-em structure of ntd-directed neutralizing antibody 5-7 in complex with prefusion sars-cov-2 spike glycoprotein |
|
13
|
134
|
7rw2G |
Cryo-em structure of ntd-directed neutralizing antibody 5-7 in complex with prefusion sars-cov-2 spike glycoprotein |
|
197
|
1116
|
7rkvA |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c118 (state 1) |
|
11
|
108
|
7ra8D |
Sars-cov-2 s glycoprotein in complex with s2x259 fab |
|
43
|
227
|
7rkvD |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c118 (state 1) |
|
216
|
1119
|
7ra8A |
Sars-cov-2 s glycoprotein in complex with s2x259 fab |
|
11
|
108
|
7r8nL |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c051 |
|
13
|
110
|
7r8mE |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c032 |
|
175
|
1123
|
7r8nA |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c051 |
|
15
|
121
|
7r8mD |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c032 |
|
16
|
129
|
7r8nH |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c051 |
|
13
|
120
|
7r8oH |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c548 |
|
167
|
1117
|
7r8mA |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c032 |
|
223
|
1123
|
7r8oA |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c548 |
|
15
|
123
|
7ra8C |
Sars-cov-2 s glycoprotein in complex with s2x259 fab |
|
10
|
114
|
7r8oL |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c548 |
|
15
|
114
|
7p78B |
Sars-cov-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation |
|
174
|
1121
|
7p78A |
Sars-cov-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation |
|
23
|
124
|
7p77W |
Sars-cov-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation |
|
190
|
1124
|
7p77B |
Sars-cov-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation |
|
15
|
114
|
7p77A |
Sars-cov-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation |
|
25
|
124
|
7p7aA |
Sars-cov-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation |
|
172
|
1124
|
7p7aB |
Sars-cov-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation |
|
177
|
1121
|
7p79A |
Sars-cov-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation. |
|
16
|
114
|
7p79B |
Sars-cov-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation. |
|
182
|
1133
|
7p7bA |
Sars-cov-2 spike protein in complex with sybody#68 in a 1up/2down conformation |
|
24
|
124
|
7p78W |
Sars-cov-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation |
|
20
|
104
|
7n8hD |
Sars-cov-2 s (b.1.429 / epsilon variant) + s2m11 + s2l20 global refinement |
|
248
|
1119
|
7n8hA |
Sars-cov-2 s (b.1.429 / epsilon variant) + s2m11 + s2l20 global refinement |
|
16
|
106
|
7n8hB |
Sars-cov-2 s (b.1.429 / epsilon variant) + s2m11 + s2l20 global refinement |
|
25
|
122
|
7n8hE |
Sars-cov-2 s (b.1.429 / epsilon variant) + s2m11 + s2l20 global refinement |
|
17
|
196
|
7lrsC |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody a23-58.1 that targets the receptor-binding domain |
|
20
|
223
|
7lrsD |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody a23-58.1 that targets the receptor-binding domain |
|
16
|
121
|
7n8hC |
Sars-cov-2 s (b.1.429 / epsilon variant) + s2m11 + s2l20 global refinement |
|
23
|
213
|
7lrsE |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody a23-58.1 that targets the receptor-binding domain |
|
274
|
1146
|
7n1vA |
Structural basis for enhanced infectivity and immune evasion of sars-cov-2 variants |
